Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis

Arch Ophthalmol. 2006 May;124(5):741-3. doi: 10.1001/archopht.124.5.741.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / etiology
  • Fluorescein Angiography
  • Humans
  • Male
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*
  • Porphyrins / therapeutic use*
  • Toxoplasmosis, Congenital / complications*
  • Toxoplasmosis, Ocular / complications*
  • Verteporfin

Substances

  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin